NIHR Maudsley BRC Blog

Our latest news & events

Latest COVID-19 Vaccine Study in the UK Launches in London

On Wednesday 14th April, the latest COVID-19 vaccine study was launched in London, with the King's Clinical Research Facility being one of the sites taking part. Sponsored by Canadian biopharmaceutical company Medicago and GlaxoSmithKline, the Phase 3 clinical trial will test the safety and efficacy of a plant-derived vaccine candidate named CoVLP.

By NIHR King's Clinical Research Facility at 14 Apr 2021

Novavax confirms vaccine provides 100% protection against severe COVID-19

Final analysis of UK Phase 3 trials of Novavax's COVID-19 vaccine reveals it provides 100% protection against severe COVID-19.

By NIHR Wellcome King's Clinical Research Facility at 16 Mar 2021

How research on chronic illnesses will improve Long-COVID-19 treatment

A new paper funded by the NIHR Maudsley BRC, published today in Oxford Open Immunology, examines prior findings in the field of neuroimmunology that suggest potential treatment strategies for patients suffering long-term symptoms from COVID-19.

By NIHR Maudsley BRC at 10 Feb 2021

Novavax trial reveals 89.3% effectiveness in preventing COVID-19

Interim analysis of study shows that the NIHR-supported Novavax COVID-19 vaccine is 89.3% effective at preventing COVID-19, including effectiveness against the new variants of concern.

By NIHR Wellcome King's Clinical Research Facility at 29 Jan 2021

The significant effect of lockdown on gambler’s mental health

King’s College London study assesses the potential impacts of COVID-19 nationwide lockdown on longer term depression, anxiety, and stress in gamblers in the UK.

 

By NIHR Maudsley BRC at 25 Jan 2021